ImmunityBio, Inc. earnings per share and revenue

IBRX earnings per share for the last quarter are -0.36 USD whereas the estimation was -0.18 USD which accounts for -100.00% surprise. Company revenue for the same period amounts to 119.50 k USD despite the estimated figure of 25.00 k USD. Estimated earnings per share for the next quarter are -0.20 USD, and revenue is expected to reach 62.50 k USD. Also watch annual changes over time to get a bigger picture of IBRX earnings per share and revenue dynamics.